Rivista 11.26

Brivaracetam as Early Add-On Treatment in Patients with Focal Seizures: A Retrospective, Multicenter, Real-World Study.

Autori: Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Cerulli Irelli E, Chiesa V, Dainese F, De Maria G, Didato G, Di Gennaro G, Falcicchio G, Fanella M, Ferlazzo E, Gangitano M, La Neve A, Mecarelli O, Montalenti E, Morano A, Piazza F, Pizzanelli C, Pulitano P, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAracetam add-on First Italian netwoRk Study (BRIVAFIRST) Group.

Data: 2022

Ambito di interesse: Epilessia

Rivista: Neurol Ther. 2022 Dec;11(4):1789-1804

Potrebbero interessarti anche:

Rivista 7.14

Doing without valproate in women of childbearing potential with idiopathic generalized epilepsy: Implications on seizure outcome.

Autori: Cerulli Irelli E, Morano A, Cocchi E, Casciato S, Fanella M, Albini M, Avorio F, Basili LM, Fisco G, Barone FA, Mascia A, D'Aniello A, Manfredi M, Fattouch J, Quarato P, Giallonardo AT, Di Gennaro G, Di Bonaventura C.

Data: 2019

Ambito di interesse: Epilessia

Rivista: Epilepsia. 2019 Dec 11

Leggi dettagli

Rivista 7,4

Management of HCV infection in the penitentiary setting in the direct-acting antivirals era: practical recommendations from an expert panel.

Autori: ranieri r et al

Data: 17 apr 2023

Ambito di interesse: infettivologico/sanità penit

Rivista: infection

Leggi dettagli

Rivista

Outcomes of allogenicstemcelltransplantation for secondary therapy-related acute myeloidleukaemia

Autori:

Data: 2012

Ambito di interesse: Ematologia

Rivista: BONE MARROW TRANSPLANTATION, ISSN: 0268-3369

Leggi dettagli

Brivaracetam as Early Add-On Treatment in Patients with Focal Seizures: A Retrospective, Multicenter, Real-World Study.

Potrebbero interessarti anche:

Doing without valproate in women of childbearing potential with idiopathic generalized epilepsy: Implications on seizure outcome.

Management of HCV infection in the penitentiary setting in the direct-acting antivirals era: practical recommendations from an expert panel.

Outcomes of allogenicstemcelltransplantation for secondary therapy-related acute myeloidleukaemia

Cosa fare per